Skip to main content

Advertisement

SpringerLink
Log in

Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis

  • Original Paper
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

N-acetyltransferase 2 (NAT2) plays an important role in the metabolism of various potential carcinogens, which can be subdivided into rapid and slow acetylation phenotype according to the different genotypes. A number of studies have been devoted to the association of NAT2 polymorphism with susceptibility to laryngeal carcinoma; however, the results were inconsistent and inconclusive. The aim of the present study was to conduct a meta-analysis assessing the possible association of NAT2 polymorphism with laryngeal cancer risk.

Methods

The relevant studies were identified through a search of PubMed, Embase, ISI Web of Knowledge, and Chinese National Knowledge Infrastructure until February 2011 and selected on the basis of the established inclusion criteria for publications, and then a meta-analysis was performed to quantitatively summarize the association of NAT2 polymorphism with laryngeal cancer susceptibility.

Results

Seven studies were included in the present meta-analysis, which described a total of 980 laryngeal cancer cases and 1,487 controls. The overall odds ratio (OR) for NAT2 slow and rapid acetylators was 0.99 (95% CI = 0.71–1.38) and 1.01 (95% CI = 0.72–1.40), respectively. When stratifying for race, the pooled ORs for NAT2 slow acetylator were 1.99 (95% CI = 1.10–3.63) in Asians and 0.85 (95% CI = 0.62–1.15) in Caucasians, and the pooled ORs for NAT2 rapid acetylator were 0.50 (95% CI = 0.28–0.91) in Asians and 1.18 (95% CI = 0.87–1.60) in Caucasians.

Conclusions

This meta-analysis suggested that there was overall lack of association between NAT2 polymorphism and laryngeal cancer risk; however, NAT2 slow acetylation may contribute to a risk factor for laryngeal cancer in Asians but not in Caucasians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

NAT2:

N-acetyltransferase 2

SCC:

Squamous cell carcinoma

OR:

Odds ratio

CI:

Confidence interval

References

  • Agundez JAG (2008) Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab 9(6):520–531

    Article  PubMed  CAS  Google Scholar 

  • Ambrosone CB, Kropp S, Yang J, Yao S, Shields PG, Chang-Claude J (2008) Cigarette smoking, N-acetyltransferase 2 genotypes, and breast cancer risk: Pooled analysis and meta-analysis. Cancer Epidemiol Biomarkers Prev 17(1):15–26. doi:10.1158/1055-9965.epi-07-0598

    Article  PubMed  CAS  Google Scholar 

  • Begg CB, Mazumdar M (1994) Operating characteristics of a bank correlation test for publication bias. Biometrics 50(4):1088–1101

    Article  PubMed  CAS  Google Scholar 

  • Bennett DA, Latham NK, Stretton C, Anderson CS (2004) Capture-recapture is a potentially useful method for assessing publication bias. J Clin Epidemiol 57(4):349–357. doi:10.1016/j.jclinepi.2003.09.015

    Article  PubMed  Google Scholar 

  • Blum M, Grant DM, McBride W, Heim M, Meyer UA (1990) Human arylamine N-acetyltransferase genes—isolation, chromosomal localization, and functional expression. DNA Cell Biol 9(3):193–203

    Article  PubMed  CAS  Google Scholar 

  • Boccia S, Cadoni G, Sayed-Tabatabaei FA, Volante M, Arzani D, De Lauretis A, Cattel C, Almadori G, Van Duijn CM, Paludetti G, Ricciardi G (2008) CYP1A1, CYP2E1, GSTM1, GSTT1, EPHX1 exons 3 and 4, and NAT2 polymorphisms, smoking, consumption of alcohol and fruit and vegetables and risk of head and neck cancer. J Cancer Res Clin Oncol 134:93–100. doi:10.1007/s00432-007-0254-5

    Article  PubMed  CAS  Google Scholar 

  • Borlak J, Reamon-Buettner SM (2006) N-acetyltransferase 2 (NAT2) gene polymorphisms in colon and lung cancer patients. BMC Med Genet 7. doi:10.1186/1471-2350-7-58

  • Brockton N, Little J, Sharp L, Cotton SC (2000) N-Acetyltransferase polymorphisms and colorectal cancer: A HuGE review. Am J Epidemiol 151(9):846–861

    PubMed  CAS  Google Scholar 

  • Butcher NJ, Boukouvala S, Sim E, Minchin RF (2002) Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J 2(1):30–42

    Article  PubMed  CAS  Google Scholar 

  • Chatzimichalis M, Xenellis J, Tzagaroulakis A, Sarof P, Banis K, Gazouli M, Bibas A (2010) GSTT1, GSTM1, GSTM3 and NAT2 polymorphisms in laryngeal squamous cell carcinoma in a Greek population. J Laryngol Otol 124(3):318–323. doi:10.1017/s002221510999154x

    Article  PubMed  CAS  Google Scholar 

  • Chen K, Jiang Q-T, He H-Q (2005) Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol 11(3):331–335

    PubMed  CAS  Google Scholar 

  • Drozdz M, Gierek T, Jendryczko A, Pilch J, Piekarska J (1987) N-acetyltransferase phenotype of patients with cancer of the larynx. Neoplasma 34(4):481–484

    PubMed  CAS  Google Scholar 

  • Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315(7109):629–634

    CAS  Google Scholar 

  • Frank SA (2004) Genetic predisposition to cancer—Insights from population genetics. Nat Rev Genet 5(10):764–772. doi:10.1038/nrg1450

    Article  PubMed  CAS  Google Scholar 

  • Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K (2005) CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res Fundam Mol Mechan Mutagen 574(1–2):112–123. doi:10.1016/j.mrfmmm.2005.01.027

    Article  CAS  Google Scholar 

  • Garcia-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein DW, Tardon A, Serra C, Carrato A, Garcia-Closas R, Lloreta J, Castano-Vinyals G, Yeager M, Welch R, Chanock S, Chatterjee N, Wacholder S, Samanic C, Tora M, Fernandez F, Real FX, Rothman N (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366(9486):649–659

    Article  PubMed  CAS  Google Scholar 

  • Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Fabianova E, Rudnai P, Brennan P (2007) Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in central europe. Am J Epidemiol 165(7):814–820. doi:10.1093/aje/kwk066

    Article  PubMed  Google Scholar 

  • Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, Devanoboyina US, Nangju NA, Feng Y (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 9(1):29–42

    PubMed  CAS  Google Scholar 

  • Henning S, Cascorbi I, Munchow B, Jahnke V, Roots I (1999) Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk. Pharmacogenetics 9(1):103–111

    Article  PubMed  CAS  Google Scholar 

  • Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Br Med J 327(7414):557–560

    Article  Google Scholar 

  • Johns LE, Houlston RS (2000) N-acetyl transferase-2 and bladder cancer risk: a meta-analysis. Environ Mol Mutagen 36(3):221–227

    Article  PubMed  CAS  Google Scholar 

  • Jourenkova-Mironova N, Wikman H, Bouchardy C, Mitrunen K, Dayer P, Benhamou S, Hirvonen A (1999) Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers. Pharmacogenetics 9(4):533–537

    PubMed  CAS  Google Scholar 

  • Koskinen WJ, Brondbo K, Dahlstrand HM, Luostarinen T, Hakulinen T, Leivo I, Molijn A, Quint WG, Roysland T, Munck-Wikland E, Makitie AA, Pyykko I, Dillner J, Vaheri A, Aaltonen LM (2007) Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. J Cancer Res Clin Oncol 133(9):673–678. doi:10.1007/s00432-007-0219-8

    Article  PubMed  Google Scholar 

  • Lei D, Pan X, Guo C, Xu F, Zhang L, Liu D, Luan X (2002) Relationship between polymorphism of N-acetyltransferase 2 and genetic susceptibility to laryngeal carcinoma. Zhonghua Zhongliu Zazhi 24(2):154–156

    PubMed  CAS  Google Scholar 

  • Marcus PM, Vineis P, Rothman N (2000) NAT2 slow acetylation and bladder cancer risk: a metaanalysis of 22 case-control studies conducted in the general population. Pharmacogenetics 10(2):115–122

    Article  PubMed  CAS  Google Scholar 

  • Morita S, Yano M, Tsujinaka T, Akiyama Y, Taniguchi M, Kaneko K, Miki H, Fujii T, Yoshino K, Kusuoka H, Monden M (1999) Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer 80(5):685–688

    Article  PubMed  CAS  Google Scholar 

  • Ochs-Balcom HM, Wiesner G, Elston RC (2007) A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer. Am J Epidemiol 166(3):246–254. doi:10.1093/aje/kwm066

    Article  PubMed  Google Scholar 

  • Rouissi K, Ouerhani S, Marrakchi R, Ben Slama MR, Sfaxi M, Ayed M, Chebil M, El Gaaied AB (2009) Combined effect of smoking and inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1 on bladder cancer in a Tunisian population. Cancer Genet Cytogenet 190(2):101–107. doi:10.1016/j.cancergencyto.2009.01.007

    Article  PubMed  CAS  Google Scholar 

  • Rydzanicz M, Wierzbicka M, Gajecka M, Szyfter W, Szyfter K (2005) The impact of genetic factors on the incidence of multiple primary tumors (MPT) of the head and neck. Cancer Lett 224(2):263–278. doi:10.1016/j.canlet.2005.01.015

    Article  PubMed  CAS  Google Scholar 

  • Unal M, Tamer L, Akbas Y, Pata YS, Vayisoglu Y, Degirmenci U, Camdeviren H (2005) Genetic polymorphism of N-acetyltransferase 2 in the susceptibility to laryngeal squamous cell carcinoma. Head Neck J Sci Spec Head Neck 27(12):1056–1060. doi:10.1002/hed.20284

    Google Scholar 

  • Varzim G, Monteiro E, Silva R, Pinheiro C, Lopes C (2002) Polymorphisms of arylamine N-acetyltransferase (NAT1 and NAT2) and larynx cancer susceptibility. ORL J Oto-Rhino-Laryngol Relat Spec 64(3):206–212

    Article  CAS  Google Scholar 

  • Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland LB, Canzian F, Haugen A (2008) A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 29(6):1164–1169. doi:10.1093/carcin/bgn020

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We are indebted to the authors of the primary studies.

Conflict of interest

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Otolaryngology-Head and Neck Surgery, Shanghai First People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200080, China

    Xin-Jiang Ying, Pin Dong, Bin Shen, Jie Wang, Sang Wang & Guo Wang

Authors
  1. Xin-Jiang Ying
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pin Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bin Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jie Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sang Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guo Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xin-Jiang Ying.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ying, XJ., Dong, P., Shen, B. et al. Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis. J Cancer Res Clin Oncol 137, 1661–1667 (2011). https://doi.org/10.1007/s00432-011-1045-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-011-1045-6

Keywords

Search

Navigation